Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open Label, Safety and Efficacy Study of Infusions of HepaStem in Urea Cycle Disorders Pediatric Patients

NCT03884959 is registered in ClinicalTrials.gov with HLB Cell Co., Ltd. as lead sponsor.

NCT NCT03884959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03884959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open Label, Safety and Efficacy Study of Infusions of HepaStem in Urea Cycle Disorders Pediatric Patients
Lead sponsor
HLB Cell Co., Ltd.
Phase
Phase 2
Overall status
Withdrawn
Start date
July 12, 2018
Completion date
November 4, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

urea cycle disorder